The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys

The epidemiological characteristics of benign prostate hyperplasia (BPH) in mainland China are not completely understood. We performed this meta-analysis to assess the prevalence of BPH from 1989 through 2014. A total of 14 articles and 19 datasets were included. The pooled overall prevalence of BPH...

Full description

Bibliographic Details
Main Authors:	Wang, Wenying, Guo, Yuwen, Zhang, Daoxin, Tian, Ye, Zhang, Xiaonan
Format:	Online
Language:	English
Published:	Nature Publishing Group 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549711/

id	pubmed-4549711
recordtype	oai_dc
spelling	pubmed-45497112015-09-04 The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys Wang, Wenying Guo, Yuwen Zhang, Daoxin Tian, Ye Zhang, Xiaonan Article The epidemiological characteristics of benign prostate hyperplasia (BPH) in mainland China are not completely understood. We performed this meta-analysis to assess the prevalence of BPH from 1989 through 2014. A total of 14 articles and 19 datasets were included. The pooled overall prevalence of BPH among men aged 40 years and older was 36.6% [95% CI, 32.3–44.8]. The occurrence rate of BPH in the age groups 40–49 years, 50–59 years, 60–69 years, 70–79 years and 80 years and older was 2.9%, 29.0%, 44.7%, 58.1% and 69.2%, respectively. The pooled occurrence rate of BPH was 41.5% [95% CI, 34.5–48.4] in urban areas and 38.6% [95% CI, 22.7–54.6] in rural areas; this difference in prevalence was not statistically significant [OR, 1.51; 95% CI, 0.97–2.36]. BPH is highly prevalent in mainland China, and its prevalence increased with age. The trend in the prevalence of BPH in mainland China was not steady; the prevalence map based on a geographic information system (GIS) showed an unequal geographic distribution. High-quality surveys on BPH with a larger sample size are needed throughout mainland China to confirm these findings. Nature Publishing Group 2015-08-26 /pmc/articles/PMC4549711/ /pubmed/26306721 http://dx.doi.org/10.1038/srep13546 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Wang, Wenying Guo, Yuwen Zhang, Daoxin Tian, Ye Zhang, Xiaonan
spellingShingle	Wang, Wenying Guo, Yuwen Zhang, Daoxin Tian, Ye Zhang, Xiaonan The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
author_facet	Wang, Wenying Guo, Yuwen Zhang, Daoxin Tian, Ye Zhang, Xiaonan
author_sort	Wang, Wenying
title	The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
title_short	The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
title_full	The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
title_fullStr	The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
title_full_unstemmed	The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
title_sort	prevalence of benign prostatic hyperplasia in mainland china: evidence from epidemiological surveys
description	The epidemiological characteristics of benign prostate hyperplasia (BPH) in mainland China are not completely understood. We performed this meta-analysis to assess the prevalence of BPH from 1989 through 2014. A total of 14 articles and 19 datasets were included. The pooled overall prevalence of BPH among men aged 40 years and older was 36.6% [95% CI, 32.3–44.8]. The occurrence rate of BPH in the age groups 40–49 years, 50–59 years, 60–69 years, 70–79 years and 80 years and older was 2.9%, 29.0%, 44.7%, 58.1% and 69.2%, respectively. The pooled occurrence rate of BPH was 41.5% [95% CI, 34.5–48.4] in urban areas and 38.6% [95% CI, 22.7–54.6] in rural areas; this difference in prevalence was not statistically significant [OR, 1.51; 95% CI, 0.97–2.36]. BPH is highly prevalent in mainland China, and its prevalence increased with age. The trend in the prevalence of BPH in mainland China was not steady; the prevalence map based on a geographic information system (GIS) showed an unequal geographic distribution. High-quality surveys on BPH with a larger sample size are needed throughout mainland China to confirm these findings.
publisher	Nature Publishing Group
publishDate	2015
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549711/
_version_	1613469132197462016

The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys

Similar Items